Iovance Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
CEOFrederick G. Vogt
CEOFrederick G. Vogt
Employees838
Employees838
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2007
Founded2007
Employees838
Employees838
IOVA Key Statistics
Market cap634.48M
Market cap634.48M
Price-Earnings ratio-1.48
Price-Earnings ratio-1.48
Dividend yield—
Dividend yield—
Average volume28.83M
Average volume28.83M
High today$1.93
High today$1.93
Low today$1.80
Low today$1.80
Open price$1.85
Open price$1.85
Volume7.78M
Volume7.78M
52 Week high$12.51
52 Week high$12.51
52 Week low$1.64
52 Week low$1.64
IOVA News
Simply Wall St 4d
Iovance Biotherapeutics, Inc.'s 46% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the Iovance Biotherapeutics, Inc. ( ) share price has dived 46% in the last thirty days, prolonging recent pain. The recent...
Analyst ratings
62%
of 13 ratingsBuy
61.5%
Hold
38.5%
Sell
0%
People also own
Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.